'Advanced
Enzyme Technologies, a leading specialty biotech company, with global
leadership in the manufacturing of enzymes & probiotics, net sales
(including other operating income) increased 5.08% to Rs 169.11 crore. Revenue from human nutrition segment decreased
by 8% to Rs 101.8 crore in Q3FY25 as compared to Rs 110.7 crore in Q3FY24. Animal nutrition delivered a growth of 22% to
Rs 19.7 crore.
Bio-Processing
segment outperformed by 36% during the quarter. It accounted for Rs 32.1 crore
in Q3 FY25 as compared to Rs 23.6 crore in Q3 FY24. In this segment, food
business grew by 39% to Rs 26.8 crore on y-o-y basis during Q3 FY25. The
Non-Food business grew by 25% to stood at Rs 5.3 crore during the quarter.
The
Specialized manufacturing segment contributed 9% in the pie which is around Rs
15.4 crore to the revenue during the quarter, an increase of 49% on y-o-y
basis.
The total
reven...
Pleaselogin & subscribe to view the full report.
More Reports
-
(03-Aug-2025)
Federal Bank
High provisions drag bottom-line
-
(02-Aug-2025)
Epigral
Deferred tax liability benefit boosted profits
-
(02-Aug-2025)
JSW Energy
Net up 42% on good operating show
-
(02-Aug-2025)
NTPC
Sales down 3%, net up 10%
|
|